Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chemed Corporation (DE:CXM)
FRANKFURT:CXM
Chemed (CXM) Stock Price & Analysis
1 Followers
CXM Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€453.37 - €605.00
Previous Close€520
Volume2.00
Average Volume (3M)15.00
Market Cap
€8.07B
Enterprise Value€7.91B
Total Cash (Recent Filing)$313.35M
Total Debt (Recent Filing)$146.14M
Price to Earnings (P/E)N/A
Beta0.03
Next Earnings
Jul 24, 2024EPS Estimate
€5.24Last Dividend Ex-Date
Feb 23, 2024Dividend Yield0.28%
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,139,240
10 Day Avg. Volume0
30 Day Avg. Volume15
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)17.07
Price to Sales (P/S)13.36
Price to Cash Flow (P/CF)25.40
P/FCF Ratio29.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.45
Enterprise Value/Gross Profit9.90
Enterprise Value/Ebitda18.59
Forecast
1Y Price Target
€647.25Price Target Upside24.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Chemed News
PremiumPre-Earnings
Is CHE a Buy, Before Earnings?Bulls Say, Bears Say
Bulls Say
Company PerformanceAnalyst maintains a Buy rating with a price objective of 708.00 USD, indicating confidence in the stock's potential.
Market ExpansionThe deal will expand Vitas’ presence in Florida and add new markets, enhancing its strategic position in its biggest state.
Strategic AcquisitionsCHE is well positioned for future acquisitions with no debt, strong cash reserves, and a favorable consolidation environment.
Bears Say
Financial PerformanceRoto's commercial revenue declined more than expected, indicating current challenges in that segment.
ProfitabilityRoto's EBITDA fell 15% below estimates due to worse revenues and margins.
RevenueRoto revenues declined 5.8% y/y, missing estimates due to tough comparisons and a decline in commercial revenues.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
7.70% Other Institutional Investors
92.30% Public Companies and
Individual Investors
CXM FAQ
What was Chemed Corporation’s price range in the past 12 months?
Chemed Corporation lowest stock price was €453.37 and its highest was €605.00 in the past 12 months.
What is Chemed Corporation’s market cap?
Currently, no data Available
When is Chemed Corporation’s upcoming earnings report date?
Chemed Corporation’s upcoming earnings report date is Jul 24, 2024 which is in 82 days.
How were Chemed Corporation’s earnings last quarter?
Chemed Corporation released its earnings results on Apr 24, 2024. The company reported €4.878 earnings per share for the quarter, missing the consensus estimate of €5.14 by -€0.263.
Is Chemed Corporation overvalued?
According to Wall Street analysts Chemed Corporation’s price is currently Undervalued.
Does Chemed Corporation pay dividends?
Chemed Corporation pays a Quarterly dividend of €0.38 which represents an annual dividend yield of 0.28%. See more information on Chemed Corporation dividends here
What is Chemed Corporation’s EPS estimate?
Chemed Corporation’s EPS estimate is €5.24.
How many shares outstanding does Chemed Corporation have?
Currently, no data Available
What happened to Chemed Corporation’s price movement after its last earnings report?
Chemed Corporation reported an EPS of €4.878 in its last earnings report, missing expectations of €5.14. Following the earnings report the stock price went down -0.877%.
Which hedge fund is a major shareholder of Chemed Corporation?
Among the largest hedge funds holding Chemed Corporation’s share is Gamco Investors, Inc. ET AL. It holds Chemed Corporation’s shares valued at 14M.
---
Chemed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€647.25 (24.47% Upside)
€647.25 (24.47% Upside)
Blogger Sentiment
Bullish
DE:CXM Sentiment 75%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.33%
12-Months-Change
Fundamentals
Return on Equity
27.47%
Trailing 12-Months
Asset Growth
20.71%
Trailing 12-Months
Company Description
Chemed Corporation
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the following segments: VITAS and Roto-Rooter. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
---
CXM Company Deck
---
CXM Earnings Call
Q1 2024
0:00 / 0:00
---
CXM Stock 12 Months Forecast
Average Price Target
€647.25
▲(24.47% Upside)
Technical Analysis
Best Analysts Covering CXM
1 Year
1 Year Success Rate
35/41 ratings generated profit
1 Year Average Return
+20.10%
reiterated a buy rating 9 days ago
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 85.37% of your transactions generating a profit, with an average return of +20.10% per trade.
---